Organoids as a tool in drug discovery and patient-specific therapy for head and neck cancer.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37343518.
- Also identified by DOI 10.1016/j.xcrm.2023.101087 and PMC identifier 10314095.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Organoids more accurately reflect tumor microenvironment than traditional models. Millen et al. demonstrated organoids replicated from patient tissues may predict patient-specific response to radiation therapy and have potential to be utilized for validation of biomarkers in drug discovery and treatment planning.
Medical subject headings
- Head and Neck Neoplasms